home / stock / proc / proc news


PROC News and Press, Procaps Group S.A. From 11/26/21

Stock Information

Company Name: Procaps Group S.A.
Stock Symbol: PROC
Market: NASDAQ

Menu

PROC PROC Quote PROC Short PROC News PROC Articles PROC Message Board
Get PROC Alerts

News, Short Squeeze, Breakout and More Instantly...

PROC - CPE, SABR and LPI among mid-day movers

Gainers: iSpecimen (NASDAQ:ISPC) +115%. Biofrontera (NASDAQ:BFRI) +68%. Allied Healthcare Products (NASDAQ:AHPI) +56%. NRx Pharmaceuticals (NASDAQ:NRXP) +52%. Adagio (NASDAQ:ADGI) +31%. Alpha Pro Tech (NYSE:APT) +23%. 180 Life Sciences (NASDAQ:ATNF) +20%. Moderna (NASDAQ:MRNA) +22%. SAB Bioth...

PROC - Procaps Group, S.A. (PROC) CEO Ruben Minski on Q3 2021 Results - Earnings Call Transcript

Procaps Group, S.A. (PROC) Q3 2021 Results Earnings Conference Call November 23, 2021, 4:30 pm ET Company Participants Chris Tyson - Investor Relations, Executive Vice President of MZ North America Ruben Minski - Founder, Chief Executive Officer and Director Patricio Vargas - Chief Financial ...

PROC - Procaps Group, S.A. 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Procaps Group, S.A. in conjunction with their 2021 Q3 earnings call. For further details see: Procaps Group, S.A. 2021 Q3 - Results - Earnings Call Presentation

PROC - Procaps Group reports Q3 results

Procaps Group (NASDAQ:PROC): Q3 net loss of $36.92M Revenue of $106.8M (+34.7% Y/Y) Press Release For further details see: Procaps Group reports Q3 results

PROC - Procaps Group Reports Record Third Quarter 2021 Financial Results

Third Quarter 2021 Net Revenues Increased 35% to $106.8 Million Year-Over-Year with Adjusted EBITDA Up 27% Year-Over-Year to $24.5 Million First Nine Months Net Revenues Increased 33% to $283.2 Million, with LTM Net Revenues at $401.4 Million and LTM Adjusted EBITDA up to $100...

PROC - Inspira Technologies, SeqLL leads healthcare gainers; Evaxion Biotech, Kiromic BioPharma among major losers

Gainers: Inspira Technologies (NASDAQ:IINN) +54%, SeqLL (NASDAQ:SQL) +46%, Ocugen (NASDAQ:OCGN) +27%, Aziyo Biologics (NASDAQ:AZYO) +15%, Roivant Sciences (NASDAQ:ROIV) +14%. Losers: Evaxion Biotech (NASDAQ:EVAX) -14%, Kiromic BioPharma (...

PROC - RIOT, BTBT and HUT among pre market gainers

LM Funding America (NASDAQ:LMFA) +45%. Sonoma Pharmaceuticals SNOA +31% with extended approval for Nanocyn in Australia ABVC BioPharma (NASDAQ:ABVC) +23%. Companhia Brasileira de Distribuicao (NYSE:CBD) +14%. Avadel Pharmaceuticals (NASDAQ:AVDL) +13%. Checkmate Pharmaceuticals CMPI&...

Previous 10 Next 10